Secondary Hematologic Malignancies After Pancreatic Chemotherapy (MP-SIR Study)

International Journal of Cancer Care and Delivery 2026 Open access

Read full text
Authors: Muzammil Hussain, Nayanika Tummala, Zahran M.Emad Alras, Chander perkash Khatri, Raja Bhawani Shanker Khatri, Madho Mal
DOI: 10.53876/001a.129670
Cited by: 0

Abstract

International Journal of Cancer Care and Deliverywith chemotherapy exposure Although the overall secondary hematologic malignancies risk remains low, there is a statistically significant and clinically relevant increase in latency-dependent Acute Myeloid Leukemia (AML) risk.These findings highlight the importance of long-term post-chemotherapy hematologic surveillance in this population.

Fields of Study & Subjects

Multiple and Secondary Primary Cancers Pancreatic and Hepatic Oncology Research Pancreatitis Pathology and Treatment

Publication details

Journal / source
International Journal of Cancer Care and Delivery
Publication date
7 February 2026
Language
EN